The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

Share Price Information for BBGI Global Infrastructure (BBGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.00
Bid: 138.80
Ask: 139.80
Change: 0.80 (0.58%)
Spread: 1.00 (0.72%)
Open: 139.00
High: 139.00
Low: 138.00
Prev. Close: 138.20
BBGI Live PriceLast checked at -
BBGI SICAV S.A. is an Investment Trust

To provide a unique access to a global portfolio of high-quality infrastructure assets which generate stable, predictable cash flows over the life of government or government-backed contracts that typically extend to more than twenty years in length.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Further Investments

25 Nov 2013 07:00

RNS Number : 7897T
Bilfinger Berger Gbl Infrstre SICAV
25 November 2013
 



25 November 2013

THIS ANNOUNCEMENT IS FOR INFORMATION ONLY AND DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER FOR SALE OR SUBSCRIPTION OF, OR SOLICITATION OF ANY OFFER TO BUY OR SUBSCRIBE FOR, ANY SHARES IN ANY JURISDICTION.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, OR INTO OR FROM CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Bilfinger Berger Global Infrastructure SICAV S.A.

Acquisition of Further Investments

Bilfinger Berger Global Infrastructure SICAV S.A. ("BBGI" or the "Company") is pleased to announce that, further to its disclosure on prospective Further Investments in its 19 November 2013 Prospectus, it has signed an agreement with Assura Group Limited (the "Assura Acquisition Agreement") in relation to the acquisition of certain equity and subordinated debt interests in two Existing Projects, being Liverpool & Sefton Clinics and North London Estates Partnerships (formerly known as Barnet & Haringey Clinics), as well as certain equity and subordinated debt interests in one of the Pipeline Assets, being Mersey Care Mental Health Hospital. The total consideration payable under the Assura Acquisition Agreement is £9.1 million.

· The Liverpool & Sefton Clinics LIFT project is a UK concession to develop, fund, build, operate and manage primary healthcare facilities in Liverpool and Sefton. Under the Assura Acquisition Agreement, BBGI will acquire 20.0% of the equity interest in the project and 26.1% of the subordinated debt. On completion of the acquisition, BBGI will control 46.6% of the equity and 52.8% of the subordinated debt.

· The North London Estates Partnership LIFT project is a UK concession to develop, fund, build, operate and manage primary healthcare facilities around Barnet, Enfield and Haringey. Under the Assura Acquisition Agreement, BBGI will acquire 20.0% of the equity interest in the project and 26.7% of the subordinated debt. On completion of the acquisition, BBGI will control 46.6% of the equity and 53.3% of the subordinated debt.

· The Mersey Care Mental Health project involves transforming the former Walton Hospital site in Liverpool into a new, 85 bed, mental health in-patient facility. Under the existing Sale and Purchase Agreement with Bilfinger Group, as announced on 15 November 2013, it is proposed that BBGI will acquire 24.5% of the equity in this project (in addition to the 13.6% of equity it already indirectly owns through its holding in Liverpool and Sefton Clinics) and 40.0% of the subordinated debt. Under the Assura Acquisition Agreement, BBGI will acquire a further 28.6% of the equity and 30.0% of the subordinated debt. On completion of both acquisitions, BBGI will control 66.7% of the equity and 70% of the subordinated debt. The asset is currently in construction although it is expected to become operational during 2014.

The Assura Acquisition Agreement is conditional on BBGI raising funding and relevant third party (including shareholder) consents from project counterparties. The acquisitions are expected to be completed in December 2013 or Q1 2014 once all such consents have been obtained.

All the assets are classified as availability-based under the investment policy of the Company and are supported by contracted, public sector-backed revenue streams, with inflation-protection characteristics.

Further information about BBGI is available on its website at www.bb-gi.com

For further information please contact:

BBGI Management Team +352 2634791

Frank Schramm

Duncan Ball

 

Maitland +44 (0)20 7379 5151

Liz Morley

 

Unless otherwise defined, the terms used in this Announcement shall have the same meaning as set out in the 19 November 2013 Prospectus.

Important Notice

This announcement is for information purposes only. This announcement is not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any shares in Bilfinger Berger Global Infrastructure SICAV S.A. (the "Company") or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.

Any investment decision must be made exclusively on the basis of any prospectus published by the Company and any supplement thereto in connection with the admission of ordinary shares of the Company ("Ordinary Shares") to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities.

Jefferies International Limited and Oriel Securities Limited (together, the Joint Sponsors) each of which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, are acting exclusively for the Company and no-one else in connection with the Issue or the matters referred to in this announcement, will not regard any other person as their respective client in relation to the Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Issue or any transaction or arrangement referred to in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBIBATMBATBAJ
Date   Source Headline
8th May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSResult of AGM
25th Apr 202411:33 amRNSAnnual Financial Report for year ended 31-Dec-2023
9th Apr 20244:02 pmRNSDirector/PDMR Shareholding
4th Apr 20241:26 pmRNSDirector/PDMR Shareholding
4th Apr 202410:11 amRNSResults analysis from Kepler Trust Intelligence
2nd Apr 20243:59 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSPeriodic SFDR Disclosure
28th Mar 20247:00 amRNSAnnual Results - financial year ended 31-Dec-2023
27th Mar 20245:02 pmRNSNotice of AGM
14th Mar 20247:00 amRNSRetail Investor Results - Investor Meet Company
26th Feb 20247:00 amRNSDate of Annual Results
15th Feb 20247:00 amRNSSecond Interim Dividend
9th Feb 20247:00 amRNSGrant of Share Awards under LTIP
31st Jan 20243:59 pmRNSDirectorate Change
12th Dec 20232:48 pmRNSDirector/PDMR Shareholding
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20239:52 amRNSDirector/PDMR Shareholding
4th Dec 202310:23 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSKepler Trust Intelligence: New Research
28th Nov 20234:09 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSDirectorate Change
27th Oct 20239:59 amRNSHolding(s) in Company
29th Sep 202310:02 amRNSTotal Voting Rights
29th Sep 20239:58 amRNSHolding(s) in Company
12th Sep 20233:26 pmRNSHalf-year Report
4th Sep 20237:00 amRNSSubstantial Completion Achieved On Highway 104
31st Aug 20237:00 amRNSDividend Declaration
31st Aug 20237:00 amRNSAdditional Listing
31st Aug 20237:00 amRNSHalf-year Report
16th Aug 20237:00 amRNSNotice of Interim Results and Results Presentation
13th Jul 20231:32 pmRNSHolding(s) in Company
30th Jun 20233:50 pmRNSDisclosure re SFDR
20th Jun 20234:50 pmRNSDirector/PDMR Shareholding
12th Jun 20237:50 amRNSPublication of 2022 ESG Report
1st Jun 20238:29 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSKepler Trust Intelligence: New Research
31st May 20232:36 pmRNSTotal Voting Rights
26th May 202310:07 amRNSAdditional Listing
10th May 202310:55 amRNSAnnual Financial Report for year ended 31 Dec 2022
28th Apr 20233:13 pmRNSTotal Voting Rights
28th Apr 20231:46 pmRNSResult of AGM
26th Apr 20232:25 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSAdditional Listing
30th Mar 20237:00 amRNSAnnual Results financial year ended 31-Dec-2022
28th Mar 20231:58 pmRNSNotice of AGM
3rd Mar 20234:34 pmRNSScrip Dividend Circular
16th Feb 20237:00 amRNSDividend Declaration
7th Feb 20237:00 amRNSDate of Annual Results
2nd Feb 20237:00 amRNSGrant of Share Awards under LTIP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.